MXPA03005004A - Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators. - Google Patents

Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators.

Info

Publication number
MXPA03005004A
MXPA03005004A MXPA03005004A MXPA03005004A MXPA03005004A MX PA03005004 A MXPA03005004 A MX PA03005004A MX PA03005004 A MXPA03005004 A MX PA03005004A MX PA03005004 A MXPA03005004 A MX PA03005004A MX PA03005004 A MXPA03005004 A MX PA03005004A
Authority
MX
Mexico
Prior art keywords
methods
cancer
colorectal cancer
breast cancer
breast
Prior art date
Application number
MXPA03005004A
Other languages
Spanish (es)
Inventor
David H Mack
Original Assignee
Protein Design Labs Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/733,757 external-priority patent/US20020102544A1/en
Priority claimed from US09/733,756 external-priority patent/US20030198951A1/en
Application filed by Protein Design Labs Inc filed Critical Protein Design Labs Inc
Publication of MXPA03005004A publication Critical patent/MXPA03005004A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Described herein are methods that can be used for diagnosis and prognosis of breast and/or colorectal cancer. Also described herein are methods that can be used to screen candidate bioactive agents for the ability to modulate breast and/or colorectal cancer. Additionally, methods and molecular targets (genes and their products) for therapeutic intervention in breast and/or colorectal cancer are described.
MXPA03005004A 2000-12-08 2001-12-10 Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators. MXPA03005004A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/733,757 US20020102544A1 (en) 2000-09-15 2000-12-08 Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
US09/733,756 US20030198951A1 (en) 1999-12-02 2000-12-08 Novel methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators
PCT/US2001/048368 WO2002059609A2 (en) 2000-12-08 2001-12-10 Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators

Publications (1)

Publication Number Publication Date
MXPA03005004A true MXPA03005004A (en) 2004-09-10

Family

ID=27112622

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03005004A MXPA03005004A (en) 2000-12-08 2001-12-10 Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators.

Country Status (5)

Country Link
EP (1) EP1410035A2 (en)
JP (1) JP2005506514A (en)
CA (1) CA2431313A1 (en)
MX (1) MXPA03005004A (en)
WO (1) WO2002059609A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2767595B1 (en) * 2006-05-22 2018-09-19 Clinical Genomics Pty Ltd Detection method for characterising the anatomical origin of a cell
KR101167392B1 (en) * 2007-07-27 2012-07-19 이매틱스 바이오테크놀로지스 게엠베하 Composition of tumour-associated peptides and related anti-cancer vaccine
EP2565204B1 (en) 2007-07-27 2015-10-07 immatics biotechnologies GmbH Novel immunogenic epitopes for immunotherapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2242437T3 (en) * 1998-11-20 2005-11-01 Genentech, Inc. USES OF AGONISTS AND ANTAGONISTS OF THE EPH RECEIVER FOR THE TREATMENT OF VASCULAR DISORDERS.
WO2001094629A2 (en) * 2000-06-05 2001-12-13 Avalon Pharmaceuticals Cancer gene determination and therapeutic screening using signature gene sets

Also Published As

Publication number Publication date
WO2002059609A3 (en) 2004-02-12
CA2431313A1 (en) 2002-08-01
WO2002059609A2 (en) 2002-08-01
JP2005506514A (en) 2005-03-03
EP1410035A2 (en) 2004-04-21

Similar Documents

Publication Publication Date Title
MXPA01009369A (en) Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators.
WO2001031335A3 (en) Cell proliferation diagnosis and screening for modulators
WO2000055629A3 (en) Methods of diagnosing and treating breast cancer
WO2002021996A3 (en) Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators
WO2002055988A3 (en) Novel methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators
WO2003025138A3 (en) Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer
WO2002059377A3 (en) Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
MXPA03001389A (en) Compositions and methods for the therapy and diagnosis of her-2/neu-associated malignancies.
WO2004070062A3 (en) Compositions and methods for diagnosing and treating cancers
WO2003042661A8 (en) Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
MXPA03001634A (en) Vaccines.
DK1053256T3 (en) Antibodies to Death Receptor 4 (DR4) and Applications thereof
AU2003205077A1 (en) Imaging agents and methods of imaging naaladase of psma
WO2002102235A3 (en) Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
MXPA04000080A (en) Diagnostic and screening methods for bladder cancer.
WO2004063355A3 (en) Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of matastatic cancer
WO2001011086A3 (en) Methods of screening for angiogenesis modulators
MX9708401A (en) Chromatin-regulator genes.
IL146125A0 (en) Novel quinones as disease therapies
IL151448A0 (en) Proteins
MXPA03005004A (en) Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators.
WO2002016939A3 (en) Methods of diagnosis of cancer and screening for cancer modulators
MXPA02011563A (en) Compositions and methods for the therapy and diagnosis of breast cancer.
AU2001233912A1 (en) Diagnosis of breast cancer using bcmp-81 as marker
WO2004041076A3 (en) Methods of detecting colorectal cancer

Legal Events

Date Code Title Description
GB Transfer or assignment